4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008753
Director sold 62 shares at $20.00 ($1,240)
- Director acquired 17,711 shares (option exercise)
- Director acquired 1,416,352 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
SHAH MAHENDRA · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-09 | Conversion : show line 1 in the form | +944,056 | 958,341 | I | ||
| 2021-02-09 | Conversion : show line 2 in the form | +472,296 | 1,430,637 | I | ||
| 2021-02-09 | Option exercise : show line 3 in the form | +17,711 | $0.07 | $1,240 | 1,448,348 | I |
| 2021-02-09 | Sale : show line 4 in the form | −62 | $20.00 | $1,240 | 1,448,286 | I |
| Open-market sales · 62 sh · avg $20.00 · $1,240 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-09 | Conversion : show line 5 in the form Series A- 1 Preferred Stock | −944,056 | 0 | I |
| 2021-02-09 | Conversion : show line 6 in the form Series B Preferred Stock | −472,296 | 0 | I |
| 2021-02-09 | Option exercise : show line 7 in the form Warrant (Right to Buy) | −17,711 | 0 | I |
Loading xslF345X03/doc4.xml…